Abstract
For patients with chronic granulomatous disease, interferon gamma therapy is an effective and well-tolerated treatment that reduces the frequency of serious infections.
Keywords
Related Publications
CD80+Gr-1+ Myeloid Cells Inhibit Development of Antifungal Th1 Immunity in Mice with Candidiasis
Abstract To find out whether polymorphonuclear neutrophils (PMN), abundantly recruited in disseminated Candida albicans infection, could directly affect the activation of Th cel...
Tumor necrosis factor α induces a caspase-independent death pathway in human neutrophils
Tumor necrosis factor α (TNF-α) is a cytokine with multiple roles in the immune system, including the induction and potentiation of cellular functions in neutrophils (PMNs). TNF...
Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells
Granzyme A lights a fire Cytotoxic T cells and natural killer cells use several strategies to kill infected or transformed cells. One such pathway entails the delivery of a fami...
Monitoring of Blood Vessels and Tissues by a Population of Monocytes with Patrolling Behavior
The cellular immune response to tissue damage and infection requires the recruitment of blood leukocytes. This process is mediated through a classical multistep mechanism, which...
Recombinant mouse <i>gamma</i> interferon induces the priming step in macrophage activation for tumor cell killing.
Abstract Mouse macrophages become activated to kill tumor cells by traversing a series of steps (1-3). The first of these does not cause the expression of cytolytic activity; in...
Publication Info
- Year
- 1991
- Type
- article
- Volume
- 324
- Issue
- 8
- Pages
- 509-516
- Citations
- 810
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1056/nejm199102213240801